These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12645433)

  • 1. Generic drugs get a life.
    Cole RT; Saputo D
    Mark Health Serv; 2003; 23(1):18-23. PubMed ID: 12645433
    [No Abstract]   [Full Text] [Related]  

  • 2. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug marketing exclusivity under United States and European Union law.
    Junod V
    Food Drug Law J; 2004; 59(4):479-518. PubMed ID: 15875347
    [No Abstract]   [Full Text] [Related]  

  • 4. PBMs' rebate income threatened by lawsuits and move to generics.
    Sipkoff M
    Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
    [No Abstract]   [Full Text] [Related]  

  • 5. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
    Kraushaar KJ
    Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
    [No Abstract]   [Full Text] [Related]  

  • 6. Mail-order sales of drugs without prescriptions under investigation by US, Canadian agencies.
    Spurgeon D
    CMAJ; 1993 Dec; 149(11):1700-1. PubMed ID: 8242510
    [No Abstract]   [Full Text] [Related]  

  • 7. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

  • 8. Price survey. Generic drug market heats up.
    Hosp Mater Manage; 2001 Mar; 26(3):1, 12-3. PubMed ID: 11975141
    [No Abstract]   [Full Text] [Related]  

  • 9. Global Generic Medicines--Health Network Communications' Second Annual Summit.
    Burck B
    IDrugs; 2008 May; 11(5):328-30. PubMed ID: 18465671
    [No Abstract]   [Full Text] [Related]  

  • 10. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV
    Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug deal.
    Rosenberg D
    Newsweek; 2002 Aug; 140(7):64-5. PubMed ID: 12195926
    [No Abstract]   [Full Text] [Related]  

  • 12. Applications for Food and Drug Administration approval to market a new drug; postmarketing reports; reporting information about authorized generic drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2009 Jul; 74(143):37163-8. PubMed ID: 19655468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Internet pharmacies: opportunities and challenges.
    Navarro RP
    Manag Care Interface; 1999 Jun; 12(6):64, 66-7. PubMed ID: 10538462
    [No Abstract]   [Full Text] [Related]  

  • 14. Authorized generic drugs, price competition, and consumers' welfare.
    Berndt ER; Mortimer R; Bhattacharjya A; Parece A; Tuttle E
    Health Aff (Millwood); 2007; 26(3):790-9. PubMed ID: 17485758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J
    Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
    [No Abstract]   [Full Text] [Related]  

  • 16. Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
    Dinh TQ
    Food Drug Law J; 2007; 62(1):77-137. PubMed ID: 17444027
    [No Abstract]   [Full Text] [Related]  

  • 17. Options to Promote Competitive Generics Markets in the United States.
    Wiske CP; Ogbechie OA; Schulman KA
    JAMA; 2015 Nov; 314(20):2129-30. PubMed ID: 26513309
    [No Abstract]   [Full Text] [Related]  

  • 18. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS
    Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807
    [No Abstract]   [Full Text] [Related]  

  • 19. Pediatric marketing exclusivity--as altered by the Best Pharmaceuticals for Children Act of 2002.
    Cooper KJ
    Food Drug Law J; 2002; 57(3):519-44. PubMed ID: 12710409
    [No Abstract]   [Full Text] [Related]  

  • 20. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
    Sturm AC
    Healthc Financ Manage; 2006 Nov; 60(11):120-2. PubMed ID: 17094287
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.